110 new crown vaccine races: aim for September!
The new crown vaccine research and development competition is still at the forefront of China and the United States. In September, the new crown vaccine may be put into emergency use.
As of May 11, the official website of the World Health Organization has filed 110 new coronary pneumonia vaccines under development, of which 8 have entered clinical trials. The reporter sorted out and found that among the eight vaccines that have entered clinical trials, four are from the Chinese research and development team, three are from the United States, and one is from the United Kingdom.
At present, at least more than 15 companies and scientific research institutions in China have launched scientific research on vaccine development, and 4 new coronavirus vaccines are undergoing clinical trials.
According to reports, the adenoviral vector vaccine of the Academy of Military Medical Sciences is the first vaccine approved for clinical trials in China.
On January 26, Chen Wei, member of the National Committee of the Chinese People's Political Consultative Conference, academician of the Chinese Academy of Engineering, and researcher of the Academy of Military Medical Sciences of the Academy of Military Sciences, was ordered to rush to the military medical expert team to Wuhan to lead the team around the pathogenic mutation of new coronavirus, rapid detection technology, vaccine antibody development Wait.
On March 16, Chen Wei led the scientific research team to develop a new coronavirus vaccine, which became the first domestic vaccine approved to enter clinical trials.
On April 10th, the 108 volunteers who completed the first phase of the clinical trial of the vaccine all ended their concentrated medical observation and were in good health.
On April 12, the vaccine was launched in phase II clinical trials, becoming the only new coronavirus vaccine that entered the phase II clinical trial in the world at that time.
When will the new crown vaccine be available?
Gao Fu, director of the China Center for Disease Control and Prevention, said in an interview with China International Television that China is at the forefront of research and development of new crown vaccines and that new crown vaccines may be put into emergency use in September.
In the European and American countries, the new crown vaccines of three R & D teams have targeted the target of obtaining emergency use authorization this fall. A new vaccine being studied by pharmaceutical giant Pfizer and German bio company BioNTech has been tested in the United States on May 4 or may be launched in September. In the UK, Oxford University research has attracted attention. Researchers say they can assess the effectiveness of the vaccine this summer, and the vaccine will be available in September.
WHO warns that new crown may become an epidemic virus, vaccine is hope
According to reports, on the 13th local time, the head of the WHO emergency health project Michael Ryan said that the new coronavirus may become a long-term problem, it is difficult to predict when the virus can be overcome, it may become an epidemic virus that will never disappear.
Michael Ryan expressed the hope that highly effective vaccines can be developed and distributed to everyone in the world.